Literature DB >> 3788996

Nine-year experience with a pharmacist-managed anticoagulation clinic.

R R Conte, W A Kehoe, N Nielson, H Lodhia.   

Abstract

A pharmacist-managed anticoagulation clinic is described, and information on patient outcome during a nine-year period is presented. Since 1974, a pharmacist has managed an anticoagulation clinic for ambulatory patients and inpatients at San Francisco General Hospital Medical Center. The pharmacist's primary responsibilities include the following: educating patients about their diseases and the importance of drug therapy, monitoring patients' vital signs, performing physical examinations, and adjusting warfarin dosage to maintain prothrombin times within the therapeutic range (1.7-2.5 times normal using control values of 1.0-1.2). These patients are also under the care of their primary physicians. The pharmacist's work is checked by the chief of the cardiac clinic at the end of each clinic session. The effectiveness of the pharmacist in managing clinic patients is reviewed periodically; from January 1975 through June 1984, the pharmacist had treated 140 patients (141 courses of therapy). Of 1792 prothrombin times taken during this time, 1060 (59.2%) were within the therapeutic range of 17-25 seconds, 510 (28.5%) were less than 17 seconds, and 222 (12.4%) were greater than 25 seconds. Only four major hemorrhagic events (0.002 hemorrhages per patient-treatment month) and 89 minor events (0.05 hemorrhages per patient-treatment month) occurred. The recurrence rate of thromboembolic events was 0.007 per patient-treatment month. Pharmacist-managed warfarin therapy in these clinic patients resulted in a level of anticoagulation control and morbidity that was acceptable to physicians.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3788996

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  11 in total

1.  Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-01       Impact factor: 2.300

2.  Pharmaceutical care.

Authors:  C D Hepler
Journal:  Pharm World Sci       Date:  1996-12

3.  Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.

Authors:  Fredric W H Chan; Raymond S M Wong; Wing-Hung Lau; Thomas Y K Chan; Gregory Cheng; Joyce H S You
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

4.  The comprehensive management of anticoagulation: ochsner coumadin clinic.

Authors:  Annette C Barrios; Hector O Ventura; Richard V Milani
Journal:  Ochsner J       Date:  2002

Review 5.  Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management.

Authors:  G P Samsa; D B Matchar
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

Review 6.  The future of anticoagulation clinics.

Authors:  Edith A Nutescu
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

Review 7.  Adverse effects of coumarin anticoagulants.

Authors:  G F Pineo; R D Hull
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

8.  Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial.

Authors:  S Jo-Anne Wilson; Philip S Wells; Michael J Kovacs; Geoffrey M Lewis; Janet Martin; Erica Burton; David R Anderson
Journal:  CMAJ       Date:  2003-08-19       Impact factor: 8.262

9.  Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic.

Authors:  A S Radley; J Hall; M Farrow; P J Carey
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

10.  Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care.

Authors:  Tammy J Bungard; Leslie Gardner; Stephen L Archer; Peter Hamilton; Bruce Ritchie; Wayne Tymchak; Ross T Tsuyuki
Journal:  Open Med       Date:  2009-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.